Skip to content
Frau in weißem Laborkittel mit Laptop in einem Gewächshaus mit vertikalen Pflanzenröhren und technischer Steuerung.

Biotechnology

Biotechnology is crucial for health, nutrition and sustainable economic activity. With cutting-edge research we are promoting the development of new therapies and vaccines, strengthening industry and agriculture and ensuring that innovations reach people faster. 

Our goals for biotechnology

In the field of biotechnology, the High-Tech Agenda Germany pursues four central goals: 

  1. A leading location for health research

    Through biotechnology we will strengthen Germany's sovereignty in developing medicine of tomorrow and thereby make Germany a leading location for health research.

  2. The most innovative location for biotechnology

    We are developing Germany into the world's most innovative location for biotechnology, thereby shaping a resource-efficient, competitive industry and increasing Germany's value creation.

  3. Resilient agricultural and food systems

    With biotechnology we are developing the resilient, crisis-proof agricultural and food systems of the future.

  4. Innovative medical technology

    We are advancing innovative medical technology for an increasingly predictive and preventive medicine of tomorrow.

Our roadmap for biotechnology

Our roadmap for biotechnology sets out key milestones and goals. These make progress measurable and provide guidance for planning and implementation.

Sub-goal 1: Gene and cell therapies

We are developing Germany into a world-leading location for the development, manufacture and commercial application of gene and cell therapies – from basic research to scalable GMP manufacturing – thereby securing a complete, sovereign value chain in Germany and Europe.

Sub-goal 2: Network University Medicine

We are establishing a joint national competence network of university hospitals so that excellent quality of care is available throughout Germany and not only at individual centres of excellence.

Sub-goal 3: Next Generation BioTech

We are unlocking the economic and scientific potential of biotechnology for Germany by specifically expanding research capacities, actively supporting start-ups and established companies in building up new bio-based value chains and thereby contributing to a significant acceleration of medical innovations.

Sub-goal 4: Entrepreneurship

We are strengthening entrepreneurship in biotechnology in Germany and supporting transfer in order to turn excellent research into globally competitive companies.

Goal 2: The most innovative location

We will develop Germany into the world's most innovative location for biotechnology, thereby shaping a resource-efficient, competitive industry and increasing Germany's value creation.

Goal 3: Agricultural and food systems

With biotechnology we will develop the resilient, crisis-proof agricultural and food systems of the future.

Mission statement

Biotechnology is a key technology for health, sustainability and economic strength. With the High-Tech Agenda we are strengthening research, transfer and industrial implementation, accelerating innovations and expanding value creation in Germany. In this way we safeguard technological sovereignty and quality of life.

The decisive factor is the systematic further development of biotechnological competencies from research through to application. The aim is to accelerate innovation processes, enable scaling and reliably translate biotechnological solutions into healthcare, sustainable production and the bioeconomy. In this way biotechnology strengthens the technological autonomy and capacity to act, economic value creation and strategic sovereignty of Germany and Europe.                                          

                               

 

 

Find out more

Measures

With a broad mix of measures we are strengthening the entire biotechnological innovation chain, from basic research through translation and clinical trials to industrial scaling and spin-offs. The aim is to translate innovations more quickly into market-ready products and healthcare delivery.

To this end we are targeting the central levers of implementation: we are improving the framework conditions for translation and clinical development, strengthening research and innovation infrastructures and supporting industrial scaling. In addition, we are developing the skilled workforce, connecting actors from science, industry and healthcare and speeding up regulatory processes.                                         

 

 

 

All measures

Levers for achieving the goals

Find out more

These framework conditions must be created if we are to succeed: 

  1. Regulation

    We are improving the framework conditions for research and development by implementing the EU's Biotech Act I, providing predictable authorisation procedures and a coherent legal framework.

  2. Data availability

    New procedures for linking data will make it possible to use data-rich methods in the development of new diagnostic and therapeutic procedures.

  3. „Important Projects of Common European Interest“ (IPCEI)

    “Important Projects of Common European Interest” (IPCEI) are used to expand the capacities for research, development and industrial application.

  4. Infrastructure

    In the case of food-grade bioreactors, regulatory authorities should take alternative usage concepts for existing facilities into account.

Market potential

Germany must strengthen its value creation and competitiveness, with biotechnology opening up market potential of more than one trillion euros through applications in medicine, industry, agriculture and the environment and through its substantial innovation and growth effects.

Explore more Roadmaps

More on Key Technologies
Person mit blauen Handschuhen hält runden Siliziumwafer mit vielen kleinen, rechteckigen Chips in Laborumgebung

Microelectronics

Microelectronics underpin almost every digital and industrial application. Find out how the High-Tech Agenda is strengthening Germany’s technological sovereignty by boosting domestic production of high-performance chips.

Quantencomputer mit goldfarbenen und schwarzen Komponenten, daneben ein Mann in weißem Kittel vor mehreren Bildschirmen mit technischen Anzeigen.

Quantum technologies

The smallest particles can make a big difference – in medicine, space travel and mobility. Find out how we aim to advance quantum technologies in Germany.

Person in weißem Schutzanzug arbeitet an einem Fusionsreaktor.

Fusion

Fusion has the potential to become an important source of emissions-free energy. Find out how the High-Tech Agenda is creating better conditions for fusion research and start-ups in Germany.

Person steht mit Laptop vor großem Bildschirm, der Programmiercode und Diagramme zeigt.

Artificial intelligence

AI already offers tremendous potential for all of us. Find out how the High-Tech Agenda aims to establish Germany as a leading hub for artificial intelligence.

 

Heck eines weißen Elektroautos an einer Reihe von Ladestationen mit angeschlossenen Ladekabeln.

Battery technologies

The mobility of the future is climate-neutral, with batteries playing a key role. Find out how we are driving the development and expansion of battery technologies in Germany and across Europe.